Works matching IS 02692813 AND DT 2025 AND VI 61 AND IP 5

Results: 62
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23

    Head‐to‐Head Comparison Between Phosphatidylethanol Versus Indirect Alcohol Biomarkers for Diagnosis of MetALD Versus MASLD: A Prospective Study.

    Published in:
    Alimentary Pharmacology & Therapeutics, 2025, v. 61, n. 5, p. 1043, doi. 10.1111/apt.18506
    By:
    • Tavaglione, Federica;
    • Amangurbanova, Maral;
    • Yang, Alexander H.;
    • Tincopa, Monica A.;
    • Ajmera, Veeral;
    • Richards, Lisa;
    • Butcher, Christian;
    • Hernandez, Christie;
    • Madamba, Egbert;
    • Singh, Seema;
    • Bettencourt, Ricki;
    • Sirlin, Claude B.;
    • Loomba, Rohit
    Publication type:
    Article
    24
    25
    26
    27
    28
    29
    30
    31

    The Impact of Postoperative Prophylactic Medication on Long‐Term Surgical, Severe Endoscopic and Endoscopic or Radiologic Recurrence Following Primary Ileocecal Resection in Patients With Crohn's Disease.

    Published in:
    Alimentary Pharmacology & Therapeutics, 2025, v. 61, n. 5, p. 1019, doi. 10.1111/apt.18496
    By:
    • ten Bokkel Huinink, Sebastiaan;
    • Bak, Michiel T. J.;
    • Beelen, Evelien M. J.;
    • Erler, Nicole S.;
    • Silverberg, Mark S.;
    • Allez, Matthieu;
    • Hoentjen, Frank;
    • Bodelier, Alexander G. L.;
    • Dijkstra, Gerard;
    • Romberg‐Camps, Marielle;
    • de Boer, Nanne K. H.;
    • Stassen, Laurents P. S.;
    • van der Meulen – de Jong, Andrea E.;
    • West, Rachel L.;
    • van der Woude, C. Janneke;
    • van Ruler, Oddeke;
    • de Vries, Annemarie C.
    Publication type:
    Article
    32
    33
    34

    Baseline Drug Clearance Predicts Outcomes in Children With Inflammatory Bowel Disease Treated With Vedolizumab: Results From the VedoKids Prospective Multicentre Study.

    Published in:
    Alimentary Pharmacology & Therapeutics, 2025, v. 61, n. 5, p. 1000, doi. 10.1111/apt.18484
    By:
    • Stein, Ronen;
    • Turner, Dan;
    • Hussey, Séamus;
    • Kawasmi, Aysha;
    • Ledder, Oren;
    • Levine, Jeremiah;
    • Markowitz, James;
    • Matar, Manar;
    • Orlanski‐Meyer, Esther;
    • Russell, Richard K.;
    • Shaoul, Ron;
    • Yerushalmy‐Feler, Anat;
    • Mould, Diane R.;
    • Conrad, Maire A.
    Publication type:
    Article
    35

    Inflammatory Potential of the Diet and Risk of Crohn's Disease and Ulcerative Colitis.

    Published in:
    Alimentary Pharmacology & Therapeutics, 2025, v. 61, n. 5, p. 1032, doi. 10.1111/apt.18497
    By:
    • Meyer, Antoine;
    • Chan, Simon S. M.;
    • Touvier, Mathilde;
    • Julia, Chantal;
    • Tjønneland, Anne;
    • Kyrø, Cecilie;
    • Dahm, Christina C.;
    • Katzke, Verena A.;
    • Schulze, Matthias B.;
    • Tumino, Rosario;
    • Sacerdote, Carlotta;
    • Masala, Giovanna;
    • Oldenburg, Bas;
    • Guevara, Marcela;
    • Bujanda, Luis;
    • Cabrera Castro, Natalia A.;
    • Tong, Tammy Y. N.;
    • Heath, Alicia K.;
    • Deschasaux‐Tanguy, Mélanie;
    • Hercberg, Serge
    Publication type:
    Article
    36
    37
    38
    39
    40
    41
    42
    43
    44
    45
    46
    47
    48
    49

    Experience With Dabigatran on Rate of Portal Vein Thrombosis Recanalization, Disease Progression and Survival.

    Published in:
    Alimentary Pharmacology & Therapeutics, 2025, v. 61, n. 5, p. 971, doi. 10.1111/apt.18474
    By:
    • Premkumar, Madhumita;
    • Bhujade, Harish;
    • Sharma, Prerna;
    • Nain, Jasvinder;
    • Ahluwalia, Jasmina;
    • Sandhu, Anchal;
    • Kumar, Yogendra;
    • Rathi, Sahaj;
    • Taneja, Sunil;
    • Duseja, Ajay Kumar;
    • Kulkarni, Anand V.;
    • Singh, Charanpreet;
    • Naseem, Shano;
    • Karki, Tanka;
    • Gupta, Pankaj;
    • Chaluvashetty, Sreedhara B.;
    • Lad, Deepesh;
    • Reddy, K. Rajender
    Publication type:
    Article
    50

    Alcohol–Related Liver Disease, Followed by Metabolic Dysfunction–Associated Steatotic Liver Disease, Emerges as the Fastest‐Growing Aetiologies for Primary Liver Cancer in the United States.

    Published in:
    Alimentary Pharmacology & Therapeutics, 2025, v. 61, n. 5, p. 959, doi. 10.1111/apt.18473
    By:
    • Danpanichkul, Pojsakorn;
    • Duangsonk, Kwanjit;
    • Kalligeros, Markos;
    • Fallon, Michael B.;
    • Vuthithammee, Chawinthorn;
    • Pan, Chun Wei;
    • Saokhieo, Preenapun;
    • Derrick, William;
    • Pang, Yanfang;
    • Chen, Vincent L.;
    • Kim, Donghee;
    • Singal, Amit G.;
    • Yang, Ju Dong;
    • Wijarnpreecha, Karn
    Publication type:
    Article